Prophylactic intramuscular vitamin K administration in newborns decreased from 2017 to 2024, according to a recent research ...

DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...

NEW HAVEN, Conn., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an ...

A new clinical trial demonstrates that hepatocyte growth factor plasmid therapy with AMG0001 is a promising, nonsurgical ...

Independent analysis examines Fridays' published TRT program structure, delivery format options, and what clinical research indicates for men evaluating prescription testosterone pathways heading into ...

Novo Nordisk grew its share prices by 8.96 percent week-on-week as investors cheered the approval of the Food and Drug ...

Investing.com -- Invivyd shares rose about 2.4% in premarket trading after the company announced that the U.S. Food and Drug Administration has granted Fast Track designation for its COVID-19 ...

Invivyd (IVVD) announced that the U.S. Food and Drug Administration has granted Fast Track designation for VYD2311, an investigational ...

Nigerian women are choosing modern family planning over tradition to improve their health, finances, and break the cycle of ...

FDA approves FUROSCIX- for use in pediatric patients weighing 43kg or aboveUSPTO issues five patents for FUROSCIX ReadyFlow Autoinjector WESTLAKE VILLAGE, Calif. and BURLINGTON, Mass., Dec. 23, 2025 ...

SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 23, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing CID-103, a potential ...

India accounts for over one-third of global rabies deaths, warns WHO. Doctors say rabies can spread through bites or ...